Anzeige
❌
Mehr »
Samstag, 21.11.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Contract Pharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
05.11.Concept Life Sciences Appoints Dean Bornilla as Chief Commercial Officer
04.11.Agilent Completes $240M Proscia Acquisition
04.11.Minghui, ASKA Agree to License and Commercialize TED Treatment in Japan
04.11.Kimia and CStone Partnership Moves Oncology Asset to Clinical Development
04.11.SK Biopharma Seeks FDA Expansion for Cenobamate
04.11.AdvanCell Names Andy Porter Chief People Officer
04.11.ARTHEx Biotech Names Christian Freitag Chief Medical Officer
04.11.Circular Genomics, PharmatrophiX Partner on Alzheimer's Biomarker Research
03.11.AGC Biologics Adds Copenhagen Site to Deal with Global Pharma Company
03.11.Shilpa CDMO Invests $50M in Peptide Manufacturing
03.11.Pfizer Removes Interim Tag, Makes Cecile Guegan CFO and EVP
03.11.Lonza to Acquire Merck KGaA's CDMO Business
02.11.Catalent Appoints Wetteny Joseph as Pharma and Consumer Health President
02.11.AbbVie, Brise Migraine Deal Hits Early Milestones
02.11.OncoC4 Welcomes Dan Janiak as Chief Business Officer
02.11.PerkinElmer Appoints Dr. Kaveh Kahen as President of Analytical & Testing Solutions
02.11.Coriolis Pharma Names Teun van der Heide New CEO
02.11.Kindeva Names Daniel Couto EVP of Inhalation & Specialty Drug Delivery
02.11.Fresenius, WuXi Biologics Sign Biosimilars Deal
30.10.Edison Scientific Inks AI Deal with Pfizer
30.10.Cambrex Breaks Ground on $120M Expansion at Charles City Site
30.10.Pace Life Sciences Completes EMA GMP Inspection at Lebanon, NJ Facility
29.10.BioMarin, GC Biopharma, Hanmi Pharm to Collaborate on Fabry Disease Treatment
29.10.Codis Completes Redundant UK Facility Demolition, Starts Construction on PSD-4 Expansion
29.10.Sanofi Launches Phase III Flu-COVID Vaccine Trial in Europe, Earning Novavax $125M